Drug Type Small molecule drug |
Synonyms GABA/sitagliptin/omeprazole |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), GABA receptor agonists(Gamma-aminobutyric acid (GABA) receptors agonists), Proton pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 2 | IL | 24 May 2023 |
Clinical | Diabetes Mellitus, Type 1 plasma C-peptide | 19 | Combination Therapy (GABA + DPP-4i + PPI), started within 12 months of insulin treatment (early therapy) | vmetnioqnh(kbsgandxtg) = Increased significantly only in the early therapy group. ywsexdkxes (xqevrvhghu ) View more | Positive | 24 May 2023 | |
Combination Therapy (GABA + DPP-4i + PPI), started after 12 months of insulin treatment (late therapy) |